Dr. Khurana is Chief of the Division of Movement Disorders at Brigham and Women’s Hospital and Harvard Medical School. He is Principal Faculty at the Harvard Stem Cell Institute and an Associate Member of the Broad Institute of Harvard and MIT. Dr. Khurana is a medical graduate of the University of Sydney, Australia, and came to Boston as a Fulbright Scholar in 2001, obtaining his Ph.D. in neurobiology from Harvard University in 2006. He completed his neurology residency at Brigham and Women’s and Massachusetts General Hospitals, and fellowship in movement disorders and ataxia at Massachusetts General Hospital. His clinical and research interests relate to neurodegenerative movement disorders, including Parkinson’s disease, multiple system atrophy (MSA) and the cerebellar ataxias.
His current research strives to understand protein-misfolding mechanisms that underlie neurodegenerative diseases. His lab integrates this fundamental knowledge with genomic and stem-cell technologies to establish personalized and precise diagnostic and therapeutic strategies for these disorders. In 2013 he co-led a study that was among the first to identify and reverse pathologies in stem cell models generated from patients with Parkinson’s disease. Dr. Khurana’s research has been recognized through awards and grants from the National Institutes of Health, American Academy of Neurology, Department of Defense, Multiple System Atrophy Coalition, National Ataxia Foundation, Michael J. Fox Foundation and Parkinson’s Disease Foundation. In 2018, Dr. Khurana was named a Robertson Stem Cell Investigator of the New York Stem Cell Foundation and in 2019 the Dr. George Cotzias Memorial Fellow of the American Parkinson’s Disease Association. He is a 2020 investigator in the Aligning Science Across Parkinson’s network.